Status:
COMPLETED
The Use of a Forecasting System for Predicting Exacerbations of COPD
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
40+ years
Phase:
EARLY_PHASE1
Brief Summary
People with Chronic Obstructive Pulmonary Disease (COPD) often have periods during the year when their symptoms become worse. These are often due to an infection and are called "exacerbations" by doct...
Eligibility Criteria
Inclusion
- Current or former smokers with a diagnosis of COPD
- Having impaired lung function as measured by spirometry
Exclusion
- History of asthma or nasal symptoms caused by hayfever
- No telephone
- Inability to record symptoms in an electronic diary (PDA)
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00788645
Start Date
August 1 2008
End Date
March 1 2009
Last Update
December 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Exeter, United Kingdom